NO20005567D0 - Innføring av nakne DNA eller RNA som koder for ikke-humane vertebrat-peptidhormoner eller cytokiner i en ikke-human vertebrat - Google Patents

Innføring av nakne DNA eller RNA som koder for ikke-humane vertebrat-peptidhormoner eller cytokiner i en ikke-human vertebrat

Info

Publication number
NO20005567D0
NO20005567D0 NO20005567A NO20005567A NO20005567D0 NO 20005567 D0 NO20005567 D0 NO 20005567D0 NO 20005567 A NO20005567 A NO 20005567A NO 20005567 A NO20005567 A NO 20005567A NO 20005567 D0 NO20005567 D0 NO 20005567D0
Authority
NO
Norway
Prior art keywords
human vertebrate
cytokines
introduction
rna encoding
peptide hormones
Prior art date
Application number
NO20005567A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005567L (no
Inventor
Stephen Martin
Paul F Russell
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20005567D0 publication Critical patent/NO20005567D0/no
Publication of NO20005567L publication Critical patent/NO20005567L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20005567A 1998-05-06 2000-11-03 Innföring av nakne DNA eller RNA som koder for ikke-humane vertebrat-peptidhormoner eller cytokiner i en ikke-human vertebrat NO20005567L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8441898P 1998-05-06 1998-05-06
PCT/US1999/006528 WO1999057275A1 (en) 1998-05-06 1999-04-15 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate

Publications (2)

Publication Number Publication Date
NO20005567D0 true NO20005567D0 (no) 2000-11-03
NO20005567L NO20005567L (no) 2000-11-03

Family

ID=22184848

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005567A NO20005567L (no) 1998-05-06 2000-11-03 Innföring av nakne DNA eller RNA som koder for ikke-humane vertebrat-peptidhormoner eller cytokiner i en ikke-human vertebrat

Country Status (11)

Country Link
US (1) US20020111323A1 (pt)
EP (1) EP1075520A1 (pt)
JP (1) JP2002513811A (pt)
CN (1) CN1297481A (pt)
AU (1) AU3739999A (pt)
BR (1) BR9909918A (pt)
CA (1) CA2324650A1 (pt)
NO (1) NO20005567L (pt)
PL (1) PL345241A1 (pt)
WO (1) WO1999057275A1 (pt)
ZA (1) ZA200005300B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
EP1322655B1 (en) 2000-01-14 2007-11-14 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Oligodeoxynucleotide and its use to induce an immune response
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
US7354909B2 (en) * 2001-08-14 2008-04-08 The United States Of America As Represented By Secretary Of The Department Of Health And Human Services Method for rapid generation of mature dendritic cells
WO2003054161A2 (en) 2001-12-20 2003-07-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
US8263091B2 (en) 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
DE102007001370A1 (de) 2007-01-09 2008-07-10 Curevac Gmbh RNA-kodierte Antikörper
KR101383476B1 (ko) 2007-11-01 2014-04-11 아스테라스 세이야쿠 가부시키가이샤 면역억제 폴리펩티드 및 핵산
CA3036251A1 (en) 2016-09-15 2018-03-22 Leidos, Inc. Pd-1 peptide inhibitors
US10799555B2 (en) 2016-09-15 2020-10-13 Leidos, Inc. PD-1 peptide inhibitors
DK3758732T3 (da) 2018-02-27 2024-10-07 Leidos Inc PD-1-peptidinhibitorer
AU2020279371A1 (en) 2019-05-22 2021-12-23 Leidos, Inc. LAG 3 binding peptides
US11338040B2 (en) 2020-06-04 2022-05-24 Leidos, Inc. Immunomodulatory compounds
US11578102B2 (en) 2020-07-31 2023-02-14 Leidos, Inc. LAG3 binding peptides
JP2023548662A (ja) 2020-10-12 2023-11-20 レイドス， インコーポレイテッド 免疫調節性ペプチド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2092983A (en) * 1982-11-08 1984-05-17 Genentech Inc. Porcine growth hormone produced by recombinant dna technology
US5693622A (en) * 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DE4303744A1 (de) * 1993-02-09 1994-08-11 Univ Autonoma De Nuevo Leon Mo Hundewachstumshormon
US6225290B1 (en) * 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation

Also Published As

Publication number Publication date
EP1075520A1 (en) 2001-02-14
BR9909918A (pt) 2000-12-26
CN1297481A (zh) 2001-05-30
AU3739999A (en) 1999-11-23
NO20005567L (no) 2000-11-03
WO1999057275A1 (en) 1999-11-11
CA2324650A1 (en) 1999-11-11
PL345241A1 (en) 2001-12-03
US20020111323A1 (en) 2002-08-15
JP2002513811A (ja) 2002-05-14
ZA200005300B (en) 2001-10-01

Similar Documents

Publication Publication Date Title
NO20005567D0 (no) Innføring av nakne DNA eller RNA som koder for ikke-humane vertebrat-peptidhormoner eller cytokiner i en ikke-human vertebrat
DE69817460D1 (de) Bildsequenzdekodierungsverfahren
NO985804D0 (no) DNA-sekvens som koder fystase av mikroorganismer
DE69933100D1 (de) Farbdatenumwandlung
DE69816465D1 (de) Verbessertes verkleidungssystem für runde säulen
DK1214097T3 (da) Nukleinsyrer kodende for polyepitop-polypeptider
DE60021503D1 (de) Destillationsverfahren für leicht polymerisierbare Substanzen enthaltende Lösungen
DE69724028D1 (de) Sperrklinkenpipette
NO20010362D0 (no) Nukleinsyrer kodende for proteiner som er involvert i sensorisk transduksjon
NO985997D0 (no) Acyltransferase samt gen som koder for acyltransferase
DE69638104D1 (de) Für Lacto-N-biosidase kodierendes Gen
ATE279393T1 (de) Neues verfahren
NO20006320D0 (no) Cykliske somatostatin-analoger
DE69829240D1 (de) Für temperaturstabiles Diaphorase Kodierendes Gen
NO20021614L (no) DNA som koder for PROST 07-polypeptid
NO20022542D0 (no) DNA som koder for et nytt PROST-Ets-polypeptid
AU2002309196A1 (en) Nucleic acids encoding olfactory receptors
NO20024029D0 (no) Nytt protein og gen som koder for proteinet
ATE241052T1 (de) Spülkasten
NO20025149D0 (no) Nukleinsyrer som koder for en ny regulator av G-protein signalisering, RGS18, og anvendelser av disse
ITMI20000344A0 (it) Peptidi tlp e sequenze di dna che li codificano
DE69735568D1 (de) Für eine Sulfotransferase kodierendes Gen
AU2250697A (en) Nucleic acid encoding an acetyl-coenzyme-a transporter protein
DK1051101T3 (da) Skyllemetode
SE9903452D0 (sv) Novel protein component and encoding nucleic acid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application